APA aipamena

Schwaederlé, M. C., Patel, S. P., Husain, H., Ikeda, M., Lanman, R. B., Banks, K. C., . . . Kurzrock, R. (2017). Utility of genomic assessment of blood-derived circulating tumor DNA (ctDNA) in patients with advanced lung adenocarcinoma. Clin Cancer Res.

Chicago Style aipamena

Schwaederlé, Maria C., Sandip P. Patel, Hatim Husain, Megumi Ikeda, Richard B. Lanman, Kimberly C. Banks, AmirAli Talasaz, Lyudmila Bazhenova, and Razelle Kurzrock. "Utility of Genomic Assessment of Blood-derived Circulating Tumor DNA (ctDNA) in Patients With Advanced Lung Adenocarcinoma." Clin Cancer Res 2017.

MLA aipamena

Schwaederlé, Maria C., et al. "Utility of Genomic Assessment of Blood-derived Circulating Tumor DNA (ctDNA) in Patients With Advanced Lung Adenocarcinoma." Clin Cancer Res 2017.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.